Amer, M., Hassan, B., Enbaya, M., Ahmad, H. (2023). Proadrenomedullin as a Cardiac Biomarker in Prediction in Pediatric Heart Failure: Review article. The Egyptian Journal of Hospital Medicine, 91(1), 4725-4730. doi: 10.21608/ejhm.2023.299491
Mohamed El Sayed Amer; Besheir Abd Alla Hassan; Mohamed Milad Abdul Hamid Enbaya; Hanan Samir Ahmad. "Proadrenomedullin as a Cardiac Biomarker in Prediction in Pediatric Heart Failure: Review article". The Egyptian Journal of Hospital Medicine, 91, 1, 2023, 4725-4730. doi: 10.21608/ejhm.2023.299491
Amer, M., Hassan, B., Enbaya, M., Ahmad, H. (2023). 'Proadrenomedullin as a Cardiac Biomarker in Prediction in Pediatric Heart Failure: Review article', The Egyptian Journal of Hospital Medicine, 91(1), pp. 4725-4730. doi: 10.21608/ejhm.2023.299491
Amer, M., Hassan, B., Enbaya, M., Ahmad, H. Proadrenomedullin as a Cardiac Biomarker in Prediction in Pediatric Heart Failure: Review article. The Egyptian Journal of Hospital Medicine, 2023; 91(1): 4725-4730. doi: 10.21608/ejhm.2023.299491
Proadrenomedullin as a Cardiac Biomarker in Prediction in Pediatric Heart Failure: Review article
Background: Children's morbidity and death from heart failure continue to be major contributing factor. The evaluation of several biomarkers may serve as a valuable diagnostic aid. Objective: To evaluate the role of Proadrenomedullin in detection of heart failure. Conclusion: There is a high diagnostic value of measuring plasma level of proADM at admission, regarding the diagnosis in the setting of pediatric congestive heart failure, and can be used as prognostic value after treatment.